发布求助
文献互助 智能选刊 最新文献

Seminars in Radiation Oncology最新文献

筛选
英文 中文
Advancing the Collaboration Between Imaging and Radiation Oncology 推进影像学与放射肿瘤学之间的合作
IF 2.6 3区 医学
Seminars in Radiation Oncology Pub Date : 2024-09-11 DOI: 10.1016/j.semradonc.2024.07.005
Xun Jia , Brett W. Carter , Aileen Duffton , Emma Harris , Robert Hobbs , Heng Li
{"title":"Advancing the Collaboration Between Imaging and Radiation Oncology","authors":"Xun Jia ,&nbsp;Brett W. Carter ,&nbsp;Aileen Duffton ,&nbsp;Emma Harris ,&nbsp;Robert Hobbs ,&nbsp;Heng Li","doi":"10.1016/j.semradonc.2024.07.005","DOIUrl":"10.1016/j.semradonc.2024.07.005","url":null,"abstract":"<div><p>The fusion of cutting-edge imaging technologies with radiation therapy (RT) has catalyzed transformative breakthroughs in cancer treatment in recent decades. It is critical for us to review our achievements and preview into the next phase for future synergy between imaging and RT. This paper serves as a review and preview for fostering collaboration between these two domains in the forthcoming decade. Firstly, it delineates ten prospective directions ranging from technological innovations to leveraging imaging data in RT planning, execution, and preclinical research. Secondly, it presents major directions for infrastructure and team development in facilitating interdisciplinary synergy and clinical translation. We envision a future where seamless integration of imaging technologies into RT will not only meet the demands of RT but also unlock novel functionalities, enhancing accuracy, efficiency, safety, and ultimately, the standard of care for patients worldwide.</p></div>","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 4","pages":"Pages 402-417"},"PeriodicalIF":2.6,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142168295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safe Hypofractionation Amid Diverse Technologies: Using Teamwork to Manage the Complexity 在多种多样的技术中实现安全的低分切技术：利用团队合作管理复杂性
IF 2.6 3区 医学
Seminars in Radiation Oncology Pub Date : 2024-09-11 DOI: 10.1016/j.semradonc.2024.08.001
Mu-Han Lin, Mona Arbab, Arnold Pompos, LaChandra Wilcox, Sepeadeh Radpour, Kajal Desai, Robert Timmerman
{"title":"Safe Hypofractionation Amid Diverse Technologies: Using Teamwork to Manage the Complexity","authors":"Mu-Han Lin,&nbsp;Mona Arbab,&nbsp;Arnold Pompos,&nbsp;LaChandra Wilcox,&nbsp;Sepeadeh Radpour,&nbsp;Kajal Desai,&nbsp;Robert Timmerman","doi":"10.1016/j.semradonc.2024.08.001","DOIUrl":"10.1016/j.semradonc.2024.08.001","url":null,"abstract":"<div><p>Radiation oncology caregivers worldwide are dedicated to advancing cancer treatment with the ultimate goal of eradicating the disease. Recognizing the inherent complexity of cancer treatment using hypo-fractionation radiotherapy (HFRT), these caregivers are committed to exploring avenues for progress and providing personalized care to each patient. Strong teams and effective workflows are an essential component to implementing safe HFRT. Every patient presents unique challenges, and as a united team of clinical and administrative professionals, radiation oncology care teams strive to drive advancements and streamline complexities in their field, guided by continuous technological innovation.</p></div>","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 4","pages":"Pages 395-401"},"PeriodicalIF":2.6,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1053429624000651/pdfft?md5=8512d5e175785b80c7b4c298011da84c&pid=1-s2.0-S1053429624000651-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142168294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Future of Education in Radiation Oncology 放射肿瘤学教育的未来
IF 2.6 3区 医学
Seminars in Radiation Oncology Pub Date : 2024-09-11 DOI: 10.1016/j.semradonc.2024.07.009
Luca Boldrini , Laura La Porta , Chiara Gasparotto , Jesper Grau Eriksen
{"title":"The Future of Education in Radiation Oncology","authors":"Luca Boldrini ,&nbsp;Laura La Porta ,&nbsp;Chiara Gasparotto ,&nbsp;Jesper Grau Eriksen","doi":"10.1016/j.semradonc.2024.07.009","DOIUrl":"10.1016/j.semradonc.2024.07.009","url":null,"abstract":"","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 4","pages":"Pages 468-473"},"PeriodicalIF":2.6,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1053429624000602/pdfft?md5=c8bd48ff749468cdd52549338fa2b4a0&pid=1-s2.0-S1053429624000602-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142168306","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global Workforce and Access: Demand, Education, Quality 全球劳动力与获取：需求、教育、质量
IF 2.6 3区 医学
Seminars in Radiation Oncology Pub Date : 2024-09-11 DOI: 10.1016/j.semradonc.2024.07.003
Surbhi Grover , Laurence Court , Sheldon Amoo-Mitchual , John Longo , Danielle Rodin , Aba Anoa Scott , Yolande Lievens , Mei Ling Yap , May Abdel-Wahab , Peter Lee , Ekaterina Harsdorf , Jamal Khader , Xun Jia , Manjit Dosanjh , Ahmed Elzawawy , Taofeeq Ige , Miles Pomper , David Pistenmaa , Patricia Hardenbergh , Daniel G Petereit , C. Norman Coleman
{"title":"Global Workforce and Access: Demand, Education, Quality","authors":"Surbhi Grover ,&nbsp;Laurence Court ,&nbsp;Sheldon Amoo-Mitchual ,&nbsp;John Longo ,&nbsp;Danielle Rodin ,&nbsp;Aba Anoa Scott ,&nbsp;Yolande Lievens ,&nbsp;Mei Ling Yap ,&nbsp;May Abdel-Wahab ,&nbsp;Peter Lee ,&nbsp;Ekaterina Harsdorf ,&nbsp;Jamal Khader ,&nbsp;Xun Jia ,&nbsp;Manjit Dosanjh ,&nbsp;Ahmed Elzawawy ,&nbsp;Taofeeq Ige ,&nbsp;Miles Pomper ,&nbsp;David Pistenmaa ,&nbsp;Patricia Hardenbergh ,&nbsp;Daniel G Petereit ,&nbsp;C. Norman Coleman","doi":"10.1016/j.semradonc.2024.07.003","DOIUrl":"10.1016/j.semradonc.2024.07.003","url":null,"abstract":"<div><p>There has long existed a substantial disparity in access to radiotherapy globally. This issue has only been exacerbated as the growing disparity of cancer incidence between high-income countries (HIC) and low and middle-income countries (LMICs) widens, with a pronounced increase in cancer cases in LMICs. Even within HICs, iniquities within local communities may lead to a lack of access to care.</p><p>Due to these trends, it is imperative to find solutions to narrow global disparities. This requires the engagement of a diverse cohort of stakeholders, including working professionals, non-governmental organizations, nonprofits, professional societies, academic and training institutions, and industry.</p><p>This review brings together a diverse group of experts to highlight critical areas that could help reduce the current global disparities in radiation oncology. Advancements in technology and treatment, such as artificial intelligence, brachytherapy, hypofractionation, and digital networks, in combination with implementation science and novel funding mechanisms, offer means for increasing access to care and education globally. Common themes across sections reveal how utilizing these new innovations and strengthening collaborative efforts among stakeholders can help improve access to care globally while setting the framework for the next generation of innovations.</p></div>","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 4","pages":"Pages 477-493"},"PeriodicalIF":2.6,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142168397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Peaks and Valleys of Photon Versus Proton Spatially Fractionated Radiotherapy 光子与质子空间分割放疗的波峰与波谷
IF 3.5 3区 医学
Seminars in Radiation Oncology Pub Date : 2024-06-14 DOI: 10.1016/j.semradonc.2024.04.007
Khadija Sheikh , Heng Li , Jean L. Wright , Theodore K. Yanagihara , Aditya Halthore
{"title":"The Peaks and Valleys of Photon Versus Proton Spatially Fractionated Radiotherapy","authors":"Khadija Sheikh ,&nbsp;Heng Li ,&nbsp;Jean L. Wright ,&nbsp;Theodore K. Yanagihara ,&nbsp;Aditya Halthore","doi":"10.1016/j.semradonc.2024.04.007","DOIUrl":"https://doi.org/10.1016/j.semradonc.2024.04.007","url":null,"abstract":"<div><p>Spatially-fractionated radiotherapy (SFRT) delivers high doses to small areas of tumor while sparing adjacent tissue, including intervening disease. In this review, we explore the evolution of SFRT technological advances, contrasting approaches with photon and proton beam radiotherapy. We discuss unique dosimetric considerations and physical properties of SFRT, as well as review the preclinical literature that provides an emerging understanding of biological mechanisms. We emphasize crucial areas of future study and highlight clinical trials that are underway to assess SFRT's safety and efficacy, with a focus on immunotherapeutic synergies. The review concludes with practical considerations for SFRT's clinical application, advocating for strategies that leverage its unique dosimetric and biological properties for improved patient outcomes.</p></div>","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 3","pages":"Pages 292-301"},"PeriodicalIF":3.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141325745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Story Behind the First Mini-BEAM Photon Radiation Treatment: What is the Mini-Beam and Why is it Such an Advance? 首例迷你 BEAM 光子放射治疗背后的故事：什么是 Mini-Beam 以及它为何如此先进？
IF 3.5 3区 医学
Seminars in Radiation Oncology Pub Date : 2024-06-14 DOI: 10.1016/j.semradonc.2024.04.003
Vijayananda Kundapur FRCR , Emina Torlakovic MD, PhD , Roland N. Auer MD, PhD
{"title":"The Story Behind the First Mini-BEAM Photon Radiation Treatment: What is the Mini-Beam and Why is it Such an Advance?","authors":"Vijayananda Kundapur FRCR ,&nbsp;Emina Torlakovic MD, PhD ,&nbsp;Roland N. Auer MD, PhD","doi":"10.1016/j.semradonc.2024.04.003","DOIUrl":"https://doi.org/10.1016/j.semradonc.2024.04.003","url":null,"abstract":"<div><p>Radiation treatment has been the cornerstone in cancer management. However, long term treatment-related morbidity always accompanies tumor control which has significant impact on quality of life of the patient who has survived the cancer. Spatially fractionated radiation has the potential to achieve both cure and to avoid dreaded long term sequelae. The first ever randomized study of mini-beam radiation treatment (MBRT) of canine brain tumor has clearly shown the ability to achieve this goal. Dogs have gyrencephalic brains functionally akin to human brain. We here report long term follow-up and final outcome of the dogs, revealing both tumor control and side effects on normal brain. The results augur potential for conducting human studies with MBRT.</p></div>","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 3","pages":"Pages 337-343"},"PeriodicalIF":3.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1053429624000237/pdfft?md5=62eb9d6f2c1d3bec07f1908e2f004c8d&pid=1-s2.0-S1053429624000237-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141325749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance” Seminars in Radiation Oncology Volume 34 (2024) 69-83 头颈部癌症磁共振引导放射治疗的使用及建议报告指南》勘误表，《放射肿瘤学研讨会》第 34 卷（2024 年），第 69-83 页
IF 3.5 3区 医学
Seminars in Radiation Oncology Pub Date : 2024-06-14 DOI: 10.1016/j.semradonc.2024.04.001
Brigid A. McDonald , Riccardo Dal Bello , Clifton D. Fuller , Panagiotis Balermpas
{"title":"Corrigendum to “The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance” Seminars in Radiation Oncology Volume 34 (2024) 69-83","authors":"Brigid A. McDonald ,&nbsp;Riccardo Dal Bello ,&nbsp;Clifton D. Fuller ,&nbsp;Panagiotis Balermpas","doi":"10.1016/j.semradonc.2024.04.001","DOIUrl":"https://doi.org/10.1016/j.semradonc.2024.04.001","url":null,"abstract":"","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 3","pages":"Page 365"},"PeriodicalIF":3.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1053429624000213/pdfft?md5=c5003876279be5664c3050f9c6144238&pid=1-s2.0-S1053429624000213-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141324492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Navigating the Critical Translational Questions for Implementing FLASH in the Clinic 在临床中实施 FLASH 的关键转化问题导航
IF 3.5 3区 医学
Seminars in Radiation Oncology Pub Date : 2024-06-14 DOI: 10.1016/j.semradonc.2024.04.008
Billy W. Loo Jr , Ioannis I. Verginadis , Brita Singers Sørensen , Anthony E. Mascia , John P. Perentesis , Albert C. Koong , Emil Schüler , Erinn B. Rankin , Peter G. Maxim , Charles L. Limoli , Marie-Catherine Vozenin
{"title":"Navigating the Critical Translational Questions for Implementing FLASH in the Clinic","authors":"Billy W. Loo Jr ,&nbsp;Ioannis I. Verginadis ,&nbsp;Brita Singers Sørensen ,&nbsp;Anthony E. Mascia ,&nbsp;John P. Perentesis ,&nbsp;Albert C. Koong ,&nbsp;Emil Schüler ,&nbsp;Erinn B. Rankin ,&nbsp;Peter G. Maxim ,&nbsp;Charles L. Limoli ,&nbsp;Marie-Catherine Vozenin","doi":"10.1016/j.semradonc.2024.04.008","DOIUrl":"https://doi.org/10.1016/j.semradonc.2024.04.008","url":null,"abstract":"<div><p>The “FLASH effect” is an increased therapeutic index, that is, reduced normal tissue toxicity for a given degree of anti-cancer efficacy, produced by ultra-rapid irradiation delivered on time scales orders of magnitude shorter than currently conventional in the clinic for the same doses. This phenomenon has been observed in numerous preclinical <em>in vivo</em> tumor and normal tissue models. While the underlying biological mechanism(s) remain to be elucidated, a path to clinical implementation of FLASH can be paved by addressing several critical translational questions. Technological questions pertinent to each beam type (<em>eg</em>, electron, proton, photon) also dictate the logical progression of experimentation required to move forward in safe and decisive clinical trials. Here we review the available preclinical data pertaining to these questions and how they may inform strategies for FLASH cancer therapy clinical trials.</p></div>","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 3","pages":"Pages 351-364"},"PeriodicalIF":3.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141325751","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovations in Physics, Biology and Clinical Translation of Spatially Fractionated and FLASH Radiotherapy 空间分割和 FLASH 放射治疗在物理学、生物学和临床转化方面的创新
IF 3.5 3区 医学
Seminars in Radiation Oncology Pub Date : 2024-06-14 DOI: 10.1016/j.semradonc.2024.05.005
Robert J. Griffin, Chandan Guha
{"title":"Innovations in Physics, Biology and Clinical Translation of Spatially Fractionated and FLASH Radiotherapy","authors":"Robert J. Griffin,&nbsp;Chandan Guha","doi":"10.1016/j.semradonc.2024.05.005","DOIUrl":"https://doi.org/10.1016/j.semradonc.2024.05.005","url":null,"abstract":"","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 3","pages":"Pages 259-261"},"PeriodicalIF":3.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141325740","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bystander Effects in Spatially Fractionated Radiation Therapy: From Molecule To Organism To Clinical Implications 空间分割放射治疗中的旁观者效应：从分子到生物体再到临床意义
IF 3.5 3区 医学
Seminars in Radiation Oncology Pub Date : 2024-06-14 DOI: 10.1016/j.semradonc.2024.05.004
Samir V. Jenkins PhD , Andrew J. Johnsrud MD , Ruud P.M. Dings PhD , Robert J. Griffin PhD
{"title":"Bystander Effects in Spatially Fractionated Radiation Therapy: From Molecule To Organism To Clinical Implications","authors":"Samir V. Jenkins PhD ,&nbsp;Andrew J. Johnsrud MD ,&nbsp;Ruud P.M. Dings PhD ,&nbsp;Robert J. Griffin PhD","doi":"10.1016/j.semradonc.2024.05.004","DOIUrl":"https://doi.org/10.1016/j.semradonc.2024.05.004","url":null,"abstract":"<div><p>The standard of care for radiation therapy is numerous, low-dose fractions that are distributed homogeneously throughout the tumor. An alternative strategy under scrutiny is to apply spatially fractionated radiotherapy (high and low doses throughout the tumor) in one or several fractions, either alone or followed by conventional radiation fractionation . Spatial fractionation allows for significant sparing of normal tissue, and the regions of tumor or normal tissue that received sublethal doses can give rise to beneficial bystander effects in both cases. Bystander effects are broadly defined as biological responses that are significantly greater than would be anticipated based on the radiation dose received. Typically these effects are initiated by diffusion of reactive oxygen species and secretion of various cytokines. As demonstrated in the literature, spatial fractionation related bystander effects can occur locally from cell to cell and in what are known as “cohort effects,” which tend to take the form of restructuring of the vasculature, enhanced immune infiltration, and development of immunological memory. Other bystander effects can take place at distant sites in what are known as “abscopal effects.” While these events are rare, they are mediated by the immune system and can result in the eradication of secondary and metastatic disease. Currently, due to the complexity and variability of these bystander effects, they are not thoroughly understood, but as knowledge improves they may present significant opportunities for improved clinical outcomes.</p></div>","PeriodicalId":49542,"journal":{"name":"Seminars in Radiation Oncology","volume":"34 3","pages":"Pages 284-291"},"PeriodicalIF":3.5,"publicationDate":"2024-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141325744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信